Cytodyn Inc (CYDY)

[fred198484]

Efficacy is most likely not the issue. The PE results should be good if past testing is a good guide. The issue is the company's finances and their communications. We know the finances are very, very bad and have to be fixed for the company to continue. It looked like the company had a good plan with the warrant conversion but that presupposed good news was coming. And it still may be coming in some form but I was certainly under the impression that we would get an interim PE reading and we did not. Nor did we get any updates on the number of patients in the trial currently. Nor did the company tell us when they thought the PE data might be available. So, what looked like a promising strategy with hope for better communication from management has now reverted to the normal bunch of question marks. Money is needed right now, but it can't really be easily obtained without some form of good news to encourage people to step up and provide the needed capital. Can someone prove to me the company has or can acquire the money it needs to keep the lights on and to get to the likely good PE results in February, perhaps? I don't think so. If someone were to work the numbers, I think you would see the company is in a pretty dire financial situation as I write this. It has been spending a lot of money to keep a variety of trials going and it just does not have that kind of money right now. And, without those PE numbers, it is not going to be easy to find additional funds. That is just the stark reality right now.